Animal Models of COVID-19: Transgenic Mouse Model
- 13 May 2022
- book chapter
- Published by Springer Nature
- Vol. 2452, 259-289
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), emerged in December 2019 in Wuhan, China, and rapidly spread throughout the world, threatening global public health. An animal model is a valuable and a crucial tool that allows understanding of nature in the pathogenesis of SARS-CoV-2 and its associated COVID-19 disease. Here we introduce detailed protocols of SARS-CoV-2 infection and COVID-19 disease using C57BL/6 (B6) transgenic mice expressing the human angiotensin-converting enzyme 2 (hACE2) from the human cytokeratin 18 promoter (K18 hACE2). To mimic natural SARS-CoV-2 infection, K18 hACE2 transgenic mice are infected intranasally under anesthesia. Upon infection, viral pathogenesis is determined by monitoring changes in body weight (morbidity) and monitoring survival (mortality), cytokine/chemokine responses, gross-lung pathology, histopathology, and viral replication in tissues. The presence of the virus and viral replication is evaluated by immunohistochemistry (IHC) and viral titrations, respectively, from the upper (nasal turbinate) and the lower (lungs) respiratory tracts, and nervous system (brain). Also, the immune response to SARS-CoV-2 infection is measured by cytokine/chemokine enzyme-linked immunosorbent assay (ELISA) from lung, spleen and brain homogenates to characterize the cytokine storm that hallmarks as one of the major causes of death caused by SARS-CoV-2 infection. This small rodent animal model based on the use of K18 hACE2 transgenic mice represents an excellent option to understand the pathogenicity of natural SARS-CoV-2 strains and its recently described Variants of Concern (VoC), and will be applicable to the identification and characterization of prophylactic (vaccine) and therapeutic (antiviral and/or neutralizing monoclonal antibodies) strategies for the prevention or treatment of SARS-CoV-2 infection or its associated COVID-19 disease. Key words COVID-19 SARS-CoV-2 hACE2 Mouse model K18 hACE2 transgenic miceKeywords
This publication has 31 references indexed in Scilit:
- Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4+T Cells Are Important in Control of SARS-CoV InfectionJournal of Virology, 2010
- Pathology of Experimental SARS Coronavirus Infection in Cats and FerretsVeterinary Pathology, 2008
- The SARS-CoV ferret model in an infection–challenge studyVirology, 2008
- Severe Acute Respiratory Syndrome Coronavirus Infection of Mice Transgenic for the Human Angiotensin-Converting Enzyme 2 Virus ReceptorJournal of Virology, 2007
- Lethal Infection of K18- hACE2 Mice Infected with Severe Acute Respiratory Syndrome CoronavirusJournal of Virology, 2007
- A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c MicePLOS Pathogens, 2007
- Aged BALB/c Mice as a Model for Increased Severity of Severe Acute Respiratory Syndrome in Elderly HumansJournal of Virology, 2005
- Severe Acute Respiratory Syndrome Coronavirus Infection of Golden Syrian HamstersJournal of Virology, 2005
- Reassessment of the rate of fixative diffusion.Journal of Clinical Pathology, 1992
- Respiratory artefact produced by carbon dioxide and pentobarbitone sodium euthanasia in ratsLaboratory Animals, 1972